US pharmacy pricing
Where to Find the Cheapest Evkeeza Price
Lowest price found · US pharmacies
$25,794.61/fill
for Evkeeza, across the pharmacies in our data
US pharmacy prices — 2.3ml of 345mg/2.3ml
| Pharmacy | Discount-card price | Regular cash price | Average retail |
|---|---|---|---|
 Kroger Pharmacy | $25,794.61Lowest | $25,797.61 | $30,875.50 |
 Harris Teeter Pharmacy | $25,794.61Lowest | $25,797.61 | $30,875.50 |
 Walgreens | $27,062.26 | $27,065.26 | $30,875.50 |
 Publix | $27,221.75 | $27,224.75 | $30,875.50 |
 Walmart Neighborhood Market | $27,693.97 | $27,696.97 | $30,875.50 |
 Walmart Pharmacy | $27,693.97 | $27,696.97 | $30,875.50 |
 Costco | $27,851.69 | $27,854.69 | $30,875.50 |
"Discount-card price" reflects a standard prescription discount card, not insurance. Prices change often — confirm at the pharmacy before filling.
Frequently asked questions
What's the cash price for Evkeeza (Evkeeza) in the US?
At the US pharmacies in our data, the lowest listed discount-card price for Evkeeza is around $25,794.61. Prices vary by pharmacy, dosage, and pack size, so use the table above to compare specific options near you.
Is a generic version of Evkeeza available?
Generic and brand-name pricing for Evkeeza is broken out in the tables above where both exist in our data. Generic versions are typically the lower-cost option, but availability depends on the specific formulation and dosage.
What is the cost of Evkeeza with insurance?
The out-of-pocket cost for Evkeeza with insurance depends on your specific plan's formulary, coverage tier, and copay or coinsurance structure. You should contact your insurance provider directly for details on your prescription coverage. If your plan does not cover Evkeeza, you may still be able to find savings through pharmacy discount programs or manufacturer patient assistance. For those with Medicare or Medicaid, coverage varies, and it's advisable to check with your plan administrator.
Is a generic version of Evkeeza available?
Evkeeza (evinacumab-dgnb) is a branded biologic medication manufactured by Regeneron Pharmaceuticals. As of now, there is no FDA-approved generic equivalent or biosimilar available on the market.